HOMOVANILLIC ACID (HVA), 24-HOUR URINE

Cancer

Report in 360Hrs

At Home

No Fasting Required

Details

Dopamine metabolite test.

₹9,176₹13,109

30% OFF

Homovanillic Acid (HVA) 24-Hour Urine Test

Why is it done?
- Test Purpose: Measures homovanillic acid (HVA), a metabolite of dopamine, in 24-hour urine to detect abnormalities in catecholamine metabolism and detect neuroendocrine tumors
- Primary Indications: Diagnosis and monitoring of pheochromocytoma, neuroblastoma, and other neuroendocrine tumors; evaluation of unexplained hypertension or palpitations; assessment of dopamine-secreting tumors
- Clinical Circumstances: Performed when patients present with symptoms of catecholamine excess (hypertension, sweating, tremor, anxiety); used in pediatric oncology screening; ordered as part of tumor surveillance in patients with known neuroendocrine malignancies
Normal Range
- Reference Values: Typically 1-8 mg/24 hours or 5-45 µmol/24 hours (ranges may vary by laboratory); reference intervals differ based on age, sex, and analytical methods used
- Units of Measurement: mg/24 hours or micromoles per 24 hours (µmol/24h); some laboratories may report in nmol/24h
- Interpretation Guidelines: Normal (negative): HVA levels within laboratory reference range indicate normal dopamine metabolism; Elevated (positive): Values above upper reference limit suggest tumor or metabolic abnormality; Borderline: Results near upper limit may warrant repeat testing or additional evaluation
- What Normal vs Abnormal Means: Normal results make neuroendocrine tumors less likely but do not completely exclude them; abnormal elevation strongly suggests presence of dopamine-producing tumor and requires further diagnostic investigation
Interpretation
- Elevated HVA Levels: Suggests pheochromocytoma, paraganglioma, or neuroblastoma; indicates dopamine-secreting tumor; may indicate other neuroendocrine malignancies; frequently associated with symptoms of catecholamine excess
- Normal HVA Levels: Makes catecholamine-secreting tumors unlikely; does not rule out non-secreting tumors; may indicate normal dopamine metabolism; helpful in excluding pheochromocytoma in hypertensive patients
- Markedly Elevated Levels (>2-3x Upper Limit): Highly suggestive of malignant neuroendocrine tumor; particularly associated with neuroblastoma in children; warrants urgent imaging and specialist consultation
- Factors Affecting Results: Medications (levodopa, sympathomimetics, decongestants, tricyclic antidepressants); stress and physical activity; caffeine and chocolate intake; improper urine collection or storage; certain foods and beverages; phenothiazines and other dopamine-blocking agents
- Clinical Significance: Elevated results carry high diagnostic value for neuroendocrine tumors; serial measurements useful for monitoring treatment response and detecting recurrence; must be interpreted with clinical symptoms and imaging findings; false positives possible with certain medications and conditions
Associated Organs
- Primary Organ Systems: Adrenal medulla (primary site of pheochromocytoma); neuroendocrine system; sympathetic nervous system; kidneys (for urine excretion); urinary system
- Associated Medical Conditions: Pheochromocytoma; paraganglioma; neuroblastoma; neuroendocrine tumors; multiple endocrine neoplasia (MEN2A and MEN2B); familial paraganglioma syndromes; von Hippel-Lindau disease; neurofibromatosis type 1
- Diseases This Test Helps Diagnose: Pheochromocytoma (primary indication); neuroblastoma (malignant pediatric tumor); dopamine-secreting tumors; paragangliomas of various locations; catecholamine-secreting carcinoid tumors; metastatic neuroendocrine malignancies
- Potential Complications of Abnormal Results: Severe hypertension and hypertensive crises from catecholamine excess; cardiac arrhythmias and myocardial infarction; stroke; pulmonary edema; spontaneous tumor rupture causing massive catecholamine release; metastatic disease and cancer progression; organ damage from chronic hypertension
Follow-up Tests
- If Elevated HVA Levels: 24-hour urine metanephrines and catecholamines; plasma free metanephrines; CT or MRI of abdomen/pelvis to localize tumor; MIBG scintigraphy (123I-MIBG) for functional imaging; PET-CT for advanced tumor staging; genetic testing for hereditary syndromes
- Complementary Diagnostic Tests: 24-hour urine vanillylmandelic acid (VMA); plasma chromogranin A; 5-HIAA (if carcinoid suspected); urinary dopamine; imaging studies (ultrasound, CT, MRI); functional imaging (MIBG, PET); bone marrow biopsy (for neuroblastoma staging)
- Monitoring Frequency for Known Conditions: For pheochromocytoma: annually during treatment surveillance; every 6-12 months after surgery to detect recurrence; for neuroblastoma: at diagnosis, during chemotherapy, and at regular intervals during follow-up (frequency depends on stage and treatment); more frequent monitoring for disseminated disease
- Related Tests: 24-hour urine metanephrines; 24-hour urine catecholamines; plasma metanephrines; chromogranin A; calcitonin (for MEN2); blood pressure monitoring; electrocardiogram; echocardiogram
Fasting Required?
- Fasting Status: No - Fasting is NOT required for this 24-hour urine collection test
- Medications to Avoid: Discontinue for 48 hours prior to collection if possible: levodopa (L-DOPA) and dopamine agonists; sympathomimetic amines (ephedrine, pseudoephedrine, phenylephrine, decongestants); tricyclic antidepressants; phenothiazines; avoid sudden discontinuation of prescribed medications without consulting physician
- Dietary Restrictions: Avoid for 48 hours before collection: chocolate and cocoa-containing products; caffeine and caffeine-containing beverages (coffee, tea, cola); bananas and citrus fruits (high in dopamine precursors); vanilla; nuts; spicy foods; aged or fermented foods
- Patient Preparation: Rest and avoid strenuous exercise for 24-48 hours before collection; avoid stress and emotional upset; remain ambulatory (not bedridden) during collection; maintain normal hydration and fluid intake; collect all urine for 24 hours in provided container with preservative
- Collection Instructions: Discard first morning void; collect all subsequent urine for exactly 24 hours; include final morning void on day 2; keep container cool (refrigerate or keep on ice); avoid contamination with stool or toilet paper; note start and end times; deliver promptly to laboratory after collection

How our test process works!